Genmab announces final humax-CD4 Phase II CTCL data - PipelineReview.com (press release)
Genmab announces final humax-CD4 Phase II CTCL dataPipelineReview.com (press release), Spain - 11 hours agoClinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood 2007; 109: 4655-4662). …
Read full story